What are peptides?
Peptides are short chains of amino acids - the same building blocks that make up proteins. The human body produces thousands of peptides naturally, and they play a central role in how the body communicates with itself. Hormones, immune signals, and tissue repair processes all involve peptides at some level.
The key point for patients researching peptide therapy is that peptides are not a single thing. The term covers a wide range of compounds with very different properties, uses, and regulatory statuses. Some peptide-based medicines are TGA-registered prescription products. Others are unapproved therapeutic goods that require specific access pathways. The category is not uniform.
What is doctor-supervised peptide therapy?
Doctor-supervised peptide therapy refers to a clinical program where a patient consults with an AHPRA-registered medical practitioner who assesses their health, reviews relevant pathology, and makes a prescribing decision based on the individual's circumstances.
The "doctor-supervised" framing matters because in Australia, peptides used therapeutically are classified as prescription-only medicines or unapproved therapeutic goods. They cannot legally be accessed without going through a proper clinical process. A practitioner who issues a prescription is taking on clinical responsibility for that decision.
What doctor-supervised therapy looks like in practice:
- An intake consultation covering health history, current medications, and goals
- A clinical assessment of whether any form of prescription care is appropriate
- Blood work or baseline testing where the practitioner considers it relevant
- A prescribing decision made individually, not applied as a standard protocol
- Dispensing through a licensed Australian pharmacy
- Ongoing monitoring and follow-up
This process varies between clinics. Understanding how each clinic structures it is one of the most useful things you can do before enquiring.
What treatment categories do Australian clinics cover?
Australian clinics offering peptide-related consultations typically focus on one or more of these areas:
Weight management and metabolic health - Programs addressing body composition, insulin sensitivity, and metabolic function. This is the largest category by clinic volume in Australia, driven significantly by the broader public awareness of GLP-1 class medicines.
Injury recovery and tissue repair - Programs focusing on musculoskeletal recovery, tendon and ligament health, and post-surgical rehabilitation. Athletes and active patients are a significant part of this group.
Healthy ageing and longevity - Programs addressing cellular health, hormonal decline associated with ageing, energy, and skin quality. This category often overlaps with IV therapy and NAD+ infusion services.
Hormone optimisation - Programs addressing testosterone, growth hormone axis, thyroid function, and related hormonal markers. Often relevant for men's health and women's hormonal health separately.
Sleep and recovery - Programs addressing sleep quality, recovery from physical training, and stress-related fatigue.
Sexual health - Programs addressing libido, erectile function, and related concerns, typically within a broader hormonal health framework.
Not every clinic covers all categories. Most specialise, which is why comparing clinics by focus area is a useful starting point.
How is peptide therapy regulated in Australia?
Australia regulates peptide products under the Therapeutic Goods Act 1989. The TGA's framework means that:
- Peptide-based medicines that are on the Australian Register of Therapeutic Goods (ARTG) are assessed for safety, quality and efficacy and are available only on prescription
- Peptide products that are not on the ARTG are classified as unapproved therapeutic goods - they have not been assessed by the TGA and can only be accessed through limited pathways including the Special Access Scheme or Authorised Prescriber pathway
- Compounded peptide medicines prepared by a licensed pharmacy for individual named patients may be lawful in appropriate circumstances, but are not evaluated by the TGA in the same way as registered medicines
Source: TGA - Unapproved therapeutic goods
The TGA issued a major safety alert in April 2026 about the rise of unapproved peptide imports and unlawful supply, reinforcing that Australian consumers must access peptide-related medicines through proper clinical and dispensing pathways: TGA - Unapproved peptide products safety alert.
What does a first consultation usually involve?
For most Australian clinics offering peptide-related consultations, the first appointment involves:
- 1A detailed intake covering health history, current medications, and relevant conditions
- 2Discussion of your goals and what you are hoping to address
- 3Blood work review or referral - many clinics require baseline pathology before prescribing
- 4A clinical assessment of whether any prescription care is appropriate for your situation
- 5If a prescription is issued, information on what to expect and how monitoring will work
A consultation can end without a prescription. Practitioners may request more information, refer you back to your GP, or determine that a particular program is not clinically appropriate. That is normal and reflects a careful process.
For a more detailed walkthrough, read what to expect at a peptide-related consultation in Australia.
Is peptide therapy safe?
This question does not have a single answer - it depends heavily on the specific medicine, the individual patient's health, the clinical process, and how the product is sourced.
The clearest safety distinction is between products accessed through proper clinical and pharmacy pathways versus products sourced from unregulated online suppliers. The TGA warns that products bought online or imported without a prescription may be counterfeit, contaminated, incorrectly dosed, or carry undisclosed ingredients. For more detail, read our guide on are peptides safe?.
Within a properly supervised clinical pathway - AHPRA-registered practitioner, individual assessment, licensed pharmacy - the risks are managed in the same way as any other prescription medicine.
Where do you start?
If you are researching peptide therapy in Australia:
- Browse the clinic directory to compare clinics by consultation type, location, focus area, and access model
- Read how to compare clinics in Australia before making contact
- Read are peptides legal in Australia? for the regulatory framework
- Read questions to ask before starting a prescribed program to prepare for a consultation
Peptide Finder is a clinic comparison directory. We do not provide medical advice, prescribe, or recommend specific treatments.